Aster DM Healthcare Share Price

  • 406.704.56 (1.14%)
  • Volume: 19,85,268
  • Closed
  • Last Updated On: 30 Aug, 2024, 03:59 PM IST
Loading...

Aster DM Healthcare Sha...

  • 406.704.56 (1.14%)
  • Volume: 19,85,268
Advertisment

Aster DM Health share price insights

View All
  • In the last 6 years, only 1.67 % trading sessions saw intraday declines higher than 5 % .

  • Sales de-grew by 69.0%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

  • 5 day moving crossover appeared yesterday. Average price decline of -2.38% within 7 days of this signal in last 5 years.

  • Stock gave a 3 year return of 105.97% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

  • Aster DM Healthcare Ltd. share price moved up by 1.14% from its previous close of Rs 402.15. Aster DM Healthcare Ltd. stock last traded price is 406.70

    Share PriceValue
    Today/Current/Last406.70
    Previous Day402.15401.95

InsightsAster DM Health

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    3.86
    EPS - TTM
    (₹)
    105.49
    MCap
    (₹ Cr.)
    20,315.20
    Sectoral MCap Rank
    8
    PB Ratio
    (x)
    3.99
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month1.70
    3 Months1.10
    6 Months0.65
    1 Year0.47
    3 Years-

    1.70
    VWAP
    (₹)
    406.36
    52W H/L
    (₹)
    558.00 / 311.10

    Aster DM Health Share Price Returns

    1 Day1.14%
    1 Week1.59%
    1 Month16.85%
    3 Months14.1%
    1 Year22.8%
    3 Years89.12%
    5 Years244.22%

    ET Stock ScreenersTop Score Companies

    Check whether Aster DM Health belongs to analysts' top-rated companies list?

    View Stock Screeners

    Aster DM Health Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Aster DM Health Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 6 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy

    That's all for Aster DM Health recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy2223
    Buy3333
    Hold111-
    Sell----
    Strong Sell----
    # Analysts6666

    Aster DM Health Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Topline Contraction

        Sales de-grew by 69.0%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
      • Employee & Interest Expense

        Company has spent 2.98% of its operating revenues towards interest expenses and 18.27% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income1,050.59977.673,718.563,325.223,224.57
      Total Income Growth (%)7.46-73.7111.833.12-1.58
      Total Expenses898.74872.613,378.013,221.143,045.12
      Total Expenses Growth (%)2.99-74.174.875.782.35
      EBIT151.85105.06340.55104.08179.45
      EBIT Growth (%)44.54-69.15227.20-42.00-40.39
      Profit after Tax (PAT)5,145.18-24.03179.21-30.794.90
      PAT Growth (%)--113.41--728.37-97.13
      EBIT Margin (%)14.4510.759.163.135.57
      Net Profit Margin (%)489.74-2.464.82-0.930.15
      Basic EPS (₹)103.34-0.483.60-0.620.10
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income6,185.13549.28537.83529.69468.72
      Total Income Growth (%)1,026.042.131.5413.016.12
      Total Expenses126.21481.71463.55452.28400.26
      Total Expenses Growth (%)-73.803.922.4913.007.29
      EBIT6,058.9267.5774.2877.4168.46
      EBIT Growth (%)0.00-9.03-4.0413.07-0.25
      Profit after Tax (PAT)6,008.24-8.1153.1959.0652.82
      PAT Growth (%)--115.25-9.9411.811.83
      EBIT Margin (%)97.9612.3013.8114.6114.61
      Net Profit Margin (%)97.14-1.489.8911.1511.27
      Basic EPS (₹)120.67-0.161.071.191.06
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3,723.7512,011.1310,303.948,658.408,776.37
      Total Revenue Growth (%)-69.0016.5719.01-1.349.74
      Total Expenses3,451.2211,477.279,667.638,456.878,426.50
      Total Expenses Growth (%)-69.9318.7214.320.3611.09
      Profit after Tax (PAT)129.28424.91525.99147.74276.61
      PAT Growth (%)-69.57-19.22256.02-46.59-16.96
      Operating Profit Margin (%)10.347.238.715.758.11
      Net Profit Margin (%)3.493.565.121.713.16
      Basic EPS (₹)2.608.5410.582.975.51
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue2,085.521,583.511,198.67768.17874.93
      Total Revenue Growth (%)31.7032.1156.04-12.2028.87
      Total Expenses1,876.171,401.181,108.71836.21810.32
      Total Expenses Growth (%)33.9026.3832.593.2028.85
      Profit after Tax (PAT)156.96173.2990.18-68.7860.61
      PAT Growth (%)-9.4292.16--213.4826.09
      Operating Profit Margin (%)14.1215.2612.00-4.2212.86
      Net Profit Margin (%)7.7011.298.07-9.217.97
      Basic EPS (₹)3.153.481.81-1.381.21

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets17,991.3114,881.2012,546.2411,643.4612,437.84
      Total Assets Growth (%)20.9018.617.75-6.3939.18
      Total Liabilities12,961.2010,020.748,063.627,809.348,719.33
      Total Liabilities Growth (%)29.3424.273.26-10.4465.87
      Total Equity5,030.114,486.084,482.623,834.123,344.13
      Total Equity Growth (%)12.130.0816.9114.651.17
      Current Ratio (x)1.251.061.151.141.10
      Total Debt to Equity (x)0.150.560.550.570.86
      Contingent Liabilities480.16365.46381.30299.39287.00
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets4,537.734,102.073,762.003,588.623,553.00
      Total Assets Growth (%)10.629.044.831.005.22
      Total Liabilities1,243.49971.51806.79724.51622.40
      Total Liabilities Growth (%)28.0020.4211.3616.4156.96
      Total Equity3,294.242,756.182,955.212,864.112,556.22
      Total Equity Growth (%)19.52-6.733.1812.04-1.91
      Current Ratio (x)3.820.780.580.600.66
      Total Debt to Equity (x)0.120.120.070.050.05
      Contingent Liabilities206.11490.33397.24323.87248.00

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 884.65 cr for investing activities which is an YoY decrease of 8.98%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities157.811,833.981,313.461,569.121,223.25
      Net Cash used in Investing Activities-884.65-971.88-570.48-330.30-667.28
      Net Cash flow from Financing Activities1,052.83-817.39-685.42-1,116.13-674.80
      Net Cash Flow332.3965.7464.78119.90-109.92
      Closing Cash & Cash Equivalent697.46365.07299.33234.55114.65
      Closing Cash & Cash Equivalent Growth (%)91.0521.9627.62104.58-48.95
      Total Debt/ CFO (x)4.241.251.671.222.03
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities412.75245.8631.9441.6698.00
      Net Cash used in Investing Activities-342.32-331.95-3.35-38.0739.75
      Net Cash flow from Financing Activities-67.0992.20-17.11-12.35-125.70
      Net Cash Flow3.346.1111.48-8.7612.06
      Closing Cash & Cash Equivalent27.7224.3818.276.7915.55
      Closing Cash & Cash Equivalent Growth (%)13.7033.44169.07-56.33345.56
      Total Debt/ CFO (x)0.941.386.193.691.43

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)2.8310.4313.304.389.54
      Return on Capital Employed (%)5.718.449.935.868.14
      Return on Assets (%)0.712.854.191.262.22
      Interest Coverage Ratio (x)5.474.995.971.691.97
      Asset Turnover Ratio (x)0.230.180.1473.9370.25
      Price to Earnings (x)158.7328.4118.6246.3017.24
      Price to Book (x)4.482.962.482.021.65
      EV/EBITDA (x)35.618.727.918.025.80
      EBITDA Margin (%)16.2913.7714.9612.9214.82
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)4.766.283.05-2.402.37
      Return on Capital Employed (%)7.066.333.91-0.962.97
      Return on Assets (%)3.454.222.39-1.911.70
      Interest Coverage Ratio (x)5.226.535.29-0.862.95
      Asset Turnover Ratio (x)0.470.390.3020.8021.40
      Price to Earnings (x)131.5869.93108.70-100.0078.74
      Price to Book (x)6.204.383.312.381.87
      EV/EBITDA (x)50.8236.5942.80109.6826.05
      EBITDA Margin (%)20.0822.0420.848.5024.60

    Financial InsightsAster DM Health

    • Income (P&L)
    • Cash Flow
      • Topline Contraction

        Sales de-grew by 69.0%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 2.98% of its operating revenues towards interest expenses and 18.27% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 884.65 cr for investing activities which is an YoY decrease of 8.98%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Aster DM Health Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Aster DM Health

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Aster DM Health

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Aster DM Health

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Aster DM Health Peer Comparison

    • Aster DM Health Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 105.97% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 105.97% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 105.97% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
      • Stock Returns vs BSE Healthcare

        Stock generated 105.97% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Aster DM Health3.864.042.835.710.71-24.3010.346.022.601.250.154.24
      Global Health63.1510.4916.4519.0111.1130.9921.4014.5917.802.440.140.69
      Narayana Hruday32.158.9927.3621.8214.0324.6819.6315.7338.861.750.501.35
      Krishna Instt of Medical Sciences64.119.6816.9614.918.0523.0320.2913.4638.751.210.572.01
      Rainbow Childrens59.6910.1717.2317.509.9926.1227.2816.8321.384.160.000.00
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Jupiter Life Line Hospitals
      • Healthcare Global
      • Yatharth Hospital
      • Artemis Medicare
      • Indraprastha Med

      Choose from Stocks

      Peers InsightsAster DM Health

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 105.97% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)

      • Stock Returns vs BSE Healthcare

        Stock generated 105.97% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Aster DM Health Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Aster DM Health Shareholding as on 30 Jun 2024
        Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
        Promoters41.8841.8841.8841.88
        Pledge98.8798.8798.8798.87
        FII27.0833.4841.0040.22
        DII16.3513.707.157.64
        Mutual Funds15.7213.597.117.54
        Others14.6810.939.9610.26
      • Showing Shareholding as on 30 Jun 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters20,92,06,32141.88 %0.00
        Pledge20,68,34,33298.87 %0.00
        FII13,52,48,35927.08 %-6.40
        DII8,16,69,48316.35 %2.65
        MF7,85,38,60815.72 %2.13
        Others7,33,88,89714.68 %3.75

      MF Ownership

      MF Ownership details are not available.

      Corporate Actions

      • Aster DM Health Board Meeting/AGM

      • Aster DM Health Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Jul 31, 2024Jul 25, 2024Board MeetingQuarterly Results
        May 28, 2024May 23, 2024Board MeetingAudited Results & Final Dividend
        Apr 12, 2024Apr 05, 2024Board MeetingInterim Dividend & Special Dividend
        Feb 08, 2024Feb 02, 2024Board MeetingQuarterly Results
        Jan 24, 2024Dec 26, 2023POM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final20%2.0Aug 22, 2024May 28, 2024
        Interim0%0.0Apr 23, 2024Apr 05, 2024
        Special1180%118.0Apr 23, 2024Apr 05, 2024
      • No other corporate actions details are available.

      About Aster DM Health

      Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 20,087.92 Crore) operating in Hospitals & Allied Services sector. Aster DM Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Other Operating Revenue, Other Services and Consultancy Income for the year ending 31-Mar-2024. Show More

      • Executives

      • Auditors

      • AM

        Azad Moopen

        Founder Chairman & Mng. Director
        AM

        Alisha Moopen

        Deputy Managing Director
        NS

        Nitish Shetty

        Chief Executive Officer
        DR

        Daniel Robert Mintz

        Non Executive Director
        Show More
      • Deloitte Haskins & Sells

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times